WeVote
Log In

Bill

Bill

S 1755

Hong Kong Judicial Sanctions Act

119th Congress Introduced by John Curtis and 2 co-sponsors

Bill S 1755 mandates public disclosure of key information about clinical trials seeking state grant funding, enhancing transparency and trust for researchers and the public.

Introduced in Senate
0
WeVote Research Nonpartisan
Bill Summary · S 1755

Summary of Bill S 1755

Bill Information

  • Bill Number: S 1755
  • Title: Requires clinical trials that apply for state grant funding to make certain information about such clinical trials public
  • Status: Referred to Health Committee
  • Introduced: January 13, 2025
  • Classification: Bill

Purpose and Intent

Bill S 1755 aims to enhance transparency in clinical trials that receive state grant funding. By mandating the public disclosure of specific information regarding these trials, the bill seeks to ensure that stakeholders, including researchers, healthcare providers, and the general public, have access to critical data about ongoing clinical research. This transparency is intended to promote trust in the research process and facilitate informed decision-making.

Key Provisions

  • Public Disclosure Requirement: The bill requires that all clinical trials applying for state grant funding must publicly disclose certain information. While the specific details of what must be disclosed are not outlined in the provided information, it typically includes aspects such as:
    • Trial objectives
    • Methodology
    • Participant eligibility criteria
    • Funding sources
    • Expected outcomes
  • Accountability Measures: The bill may include provisions for accountability to ensure compliance with the disclosure requirements, although specific enforcement mechanisms are not detailed in the provided information.

Affected Parties

  • Researchers and Institutions: Those conducting clinical trials will need to adhere to the new disclosure requirements when seeking state funding.
  • Healthcare Providers: Access to trial information will enable healthcare professionals to make better-informed decisions regarding patient care and treatment options.
  • General Public: Increased transparency will empower patients and the public to understand ongoing clinical research, potentially leading to greater engagement and trust in medical research.

Procedural Aspects

  • Current Status: As of January 13, 2025, the bill has been referred to the Health Committee for further consideration. The timeline for additional legislative actions, such as hearings or votes, has not been specified.
  • Related Bills: This bill is related to prior-session bills S 8190 and S 1523, as well as a companion bill A 5151, which may address similar issues or provide additional context for the current legislative effort.

Conclusion

Bill S 1755 represents a significant step toward increasing transparency in clinical trials funded by state grants. By requiring public disclosure of key trial information, the bill aims to foster trust and informed participation in the clinical research process. Stakeholders should monitor the bill's progress through the legislative process for any developments or changes to its provisions.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.